.Genentech is going to shut its cancer immunology study department, and system head as well as popul...
.Kezar Life Sciences is dropping its dim phase 1 strong growth medication as the biotech goes all-in...
.Despite izokibep maintaining its newfound winning streak in the clinic, Acelyrin is no more focusin...
.Rivus Pharmaceuticals has plumped up the customers of its own fat-busting, muscle-sparing medicine ...
.Ovid Therapy currently disclosed last month that it was actually trimming its head count as the bus...
.Eli Lilly has opened up a $700 thousand R&D facility in the Boston ma Seaport, boosting its own ...
.Merely five months after securing a $100 million IPO, Vast Bio is presently laying off some staff m...
.The first phases of oncology R&D may not be short of fascinating brand-new modalities, and Halda...
.Psychopharmacology has actually taken 3 short articles concerning midstage clinical test informatio...
.Avidity Biosciences amazed clients along with period 1/2 data in Duchenne muscle dystrophy (DMD) Fr...